| |
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
 |
| |
|
| 제 목 |
FfrJtHfWeVUxIA |
|
| 이 름 |
Lance |
날 짜 |
2018/06/29 |
조 회 |
30 |
|
Remove card www.dietdoctor.com/lchf Karen Lu, M.D., of the University of Texas MD Anderson Cancer Center in Houston, led a study testing an ovarian cancer screening method that incorporates changes in CA125, a blood protein known as a tumor marker for the disease. The method involves two stages of testing and is designed to detect changes in CA125.
|
|
|
 |
|
| |
|
|
|
| |
|
|
|
|
|
| |
|
|
|
